Itopride Pellets
Request a Quote

Itopride Pellets

( Sustained Release  |  Enteric Coated  |  Instant Release )
( Multiple-Unit Pellet System )

Itopride (INN) is a prokinetic benzamide derivative unlike metoclopramide or domperidone.

These drugs inhibit dopamine and have a gastrokinetic effect.

Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions.

Itopride is not currently approved by the U.S. Food and Drug Administration (FDA) for use in the United States, nor is it yet approved in the United Kingdom.

Available Form :
  1. Itopride HCL SR Pellets
  2. Itopride Hydrochloride
  3. Itopride Granules
Itopride Pellets Systematic (IUPAC) Name Itopride Pellets Identifiers Itopride Pellets Chemical data
N-[[4-(2-Dimethylaminoethoxy)phenyl]methyl]-3,4-dimethoxybenzamide
  • CAS number : 122898-67-3
  • PubChem : CID 3792
  • UNII : 81BMQ80QRL
  • DrugBank : APRD00984
  • KEGG : D08094
  • ATC code : None
  • Formula : C20H26N2O4
  • Mol. mass : 358.43 g/mol

We supply Itopride in pellets form and granules form. Our Itopride Pellets can be used in a variety of Pharmaceutical applications like It can be used in tablets and capsules.

We also offer Sustained Release(SR) / Immediate Release (IR) and Enteric Coated (EC) Itopride Pellets.

Umang pharmatech has the capability to manufacture Itopride Pellets of various particle sizes.

See Products by Category